Application Nr Approved Date Route Status External Links
ANDA078992 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Dexmethylphenidate Hydrochloride Extended-Release Capsules Is Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) [See Clinical Studies (14) ] . Dexmethylphenidate Hydrochloride Extended-Release Capsules Is A Central Nervous System (Cns) Stimulant Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) In Patients Aged 6 Years And Older

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dexmethylphenidate Hydrochloride DEXMETHYLPHENIDATE HYDROCHLORIDE ZINC896711

Comments